PMID- 35584505 OWN - NLM STAT- MEDLINE DCOM- 20220520 LR - 20220716 IS - 1678-7765 (Electronic) IS - 1678-7757 (Print) IS - 1678-7757 (Linking) VI - 30 DP - 2022 TI - Decreased CD1a + and CD83 + cells in tonsillar squamous cell carcinoma regardless of HPV status. PG - e20210702 LID - S1678-77572022000100425 [pii] LID - 10.1590/1678-7757-2020-0702 [doi] LID - e20210702 AB - BACKGROUND: Dendritic cells (DCs) are specialized antigen-presenting cells that play a critical role in the immune response against human papillomavirus (HPV) infection, and represent a therapeutic target in cancer. OBJECTIVE: To identify and quantify DCs in tonsillar squamous cell carcinoma (TSCC) under the influence of HPV infection. METHODOLOGY: CD1a and CD83 antibodies were used to identify immature dendritic cells and mature dendritic cells by immunohistochemistry in 33 primary TSCC and 10 normal tonsils (NTs), respectively. For the TSCC samples, the number of DCs per area was evaluated in the intra- and peritumoral compartments. For the NTs, the quantification of DCs was evaluated in the intra- and peritonsillar compartments. HPV detection methods were determined according to the ASCO Clinical Practice Guidelines from the College of American Pathologists Guideline (2018). RESULTS: There were fewer intratumoral CD1a+ DCs in the HPV-positive and HPV-negative TSCC groups than in the NT group (p<0.05). In the peritumoral compartment, there were fewer CD83+ DCs in the HPV-positive and HPV-negative TSCC groups than in the NT group (p<0.001). The quantification of DCs subtypes showed no statistical differences between HPV-positive and HPV-negative TSCC groups (p>0.137). Patients with HPV-positive TSCC had significantly better overall survival rate than those with HPV-negative TSCC (p=0.004). CONCLUSION: Tumor activity contributes to DC depletion regardless of intralesional HPV positivity. An improved prognosis has been reported in patients with HPV-positive TSCC. FAU - Gama-Cuellar, Ana Guadalupe AU - Gama-Cuellar AG AUID- ORCID: 0000-0002-4410-3322 AD - Universidade Federal de Santa Catarina - UFSC, Departamento de Patologia, Florianopolis, SC, Brasil. FAU - Francisco, Ana Lucia Noronha AU - Francisco ALN AUID- ORCID: 0000-0003-0408-614X AD - Hospital AC Camargo, Servico de Cabeca e Pescoco, Sao Paulo, SP, Brasil. FAU - Scarini, Joao Figueira AU - Scarini JF AUID- ORCID: 0000-0001-9015-6831 AD - Universidade Estadual de Campinas - UNICAMP, Departamento de Anatomia-Patologica, Faculdade de Ciencias Medicas, Campinas, SP, Brasil. FAU - Mariano, Fernanda Viviane AU - Mariano FV AUID- ORCID: 0000-0003-3694-5025 AD - Universidade Estadual de Campinas - UNICAMP, Departamento de Anatomia-Patologica, Faculdade de Ciencias Medicas, Campinas, SP, Brasil. FAU - Kowalski, Luiz Paulo AU - Kowalski LP AUID- ORCID: 0000-0002-0481-156X AD - Hospital AC Camargo, Servico de Cabeca e Pescoco, Sao Paulo, SP, Brasil. FAU - Gondak, Rogerio AU - Gondak R AUID- ORCID: 0000-0001-7547-660X AD - Universidade Federal de Santa Catarina - UFSC, Departamento de Patologia, Florianopolis, SC, Brasil. LA - eng PT - Journal Article DEP - 20220516 PL - Brazil TA - J Appl Oral Sci JT - Journal of applied oral science : revista FOB JID - 101189774 SB - IM MH - *Carcinoma, Squamous Cell/pathology MH - Humans MH - Immunohistochemistry MH - *Papillomavirus Infections MH - Prognosis MH - *Tonsillar Neoplasms/pathology PMC - PMC9126112 COIS- Conflict of interest The authors declare no conflict of interest. EDAT- 2022/05/19 06:00 MHDA- 2022/05/21 06:00 PMCR- 2022/05/16 CRDT- 2022/05/18 17:04 PHST- 2021/12/22 00:00 [received] PHST- 2022/04/06 00:00 [accepted] PHST- 2022/05/18 17:04 [entrez] PHST- 2022/05/19 06:00 [pubmed] PHST- 2022/05/21 06:00 [medline] PHST- 2022/05/16 00:00 [pmc-release] AID - S1678-77572022000100425 [pii] AID - 10.1590/1678-7757-2020-0702 [doi] PST - epublish SO - J Appl Oral Sci. 2022 May 16;30:e20210702. doi: 10.1590/1678-7757-2020-0702. eCollection 2022.